Back to search

Article

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies

2021-10-01

Abstract excerpt

Understanding of the molecular mechanisms of prostate cancer has led to development of therapeutic strategies targeting androgen receptor (AR). These androgen-receptor signaling inhibitors (ARSI) include androgen synthesis inhibitor- abiraterone and androgen receptor antagonists- enzalutamide, apalutamide, and darolutamide. Although these medications provide significant improvement in survival among men with prost...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
af1f9feb-c297-5917-99d6-aead9898731d
DOI
10.20944/preprints202110.0016.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Androgen Receptor Signaling in Prostate Cancer and Therapeutic StrategiesDOI 10.20944/preprints202110.0016.v1
Select a neighboring publication to make it the new centre.